| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.92B | 64.55B | 67.38B | 61.48B | 60.73B | 55.22B |
| Gross Profit | 11.98B | 11.66B | 12.62B | 10.83B | 10.39B | 9.24B |
| EBITDA | 6.99B | 6.94B | 8.17B | 6.84B | 6.99B | 6.30B |
| Net Income | 3.73B | 3.71B | 4.63B | 3.92B | 3.78B | 3.76B |
Balance Sheet | ||||||
| Total Assets | 76.37B | 77.57B | 72.92B | 66.79B | 60.95B | 55.81B |
| Cash, Cash Equivalents and Short-Term Investments | 17.40B | 20.21B | 20.23B | 14.59B | 14.00B | 8.04B |
| Total Debt | 3.20B | 3.52B | 3.52B | 4.11B | 5.06B | 5.94B |
| Total Liabilities | 25.22B | 26.30B | 22.96B | 25.17B | 21.96B | 24.97B |
| Stockholders Equity | 51.11B | 51.27B | 49.96B | 41.62B | 38.99B | 30.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.42B | 3.74B | 3.17B | 7.55B | -3.17B |
| Operating Cash Flow | 0.00 | 7.80B | 5.27B | 4.08B | 8.69B | -2.04B |
| Investing Cash Flow | 0.00 | -5.21B | -996.00M | -1.23B | -1.94B | -2.96B |
| Financing Cash Flow | 0.00 | -2.90B | 2.00B | -2.26B | -2.09B | 2.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥52.68B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
73 Outperform | ¥56.75B | 10.18 | ― | 4.90% | 4.91% | 57.89% | |
70 Outperform | ¥50.61B | 18.57 | ― | 3.53% | -2.95% | -35.66% | |
68 Neutral | ¥48.69B | 4.67 | ― | 2.26% | 12.93% | 98.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥49.17B | 20.04 | ― | 5.38% | -9.27% | -6.86% | |
60 Neutral | ¥62.67B | 19.35 | ― | 1.57% | 11.01% | 231.83% |